Bangalore: 27th October 2011
A global initiative to develop new tuberculosis vaccines to supplement the now 90-year-old Bacille Calmette-Guérin (BCG), commonly administered to infants as part of vaccination protocols, will feature India as one of the sites for trials.
Read more
A global initiative to develop new tuberculosis vaccines to supplement the now 90-year-old Bacille Calmette-Guérin (BCG), commonly administered to infants as part of vaccination protocols, will feature India as one of the sites for trials.
Read more
RSS Feed
